How does Lisata Therapeutics have a negative enterprise value?
Lisata Therapeutics Inc (NASDAQ:LSTA) finds itself in an extraordinary but not unusual position emblematic of the challenges faced by small-cap biotech...…
1,481$
-0,59%
Echtzeit-Aktienkurs Pliant Therapeutics Inc.
Bid:
Ask:
Nachrichten zur Pliant Therapeutics Inc. Aktie
Pliant Therapeutics Presents Data from its Bexotegrast Program at the American Thoracic Society International Conference
SOUTH SAN FRANCISCO, Calif., May 21, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology…
Lisata Therapeutics receives waiver for pediatric studies of certepetide in pancreatic cancer
Lisata Therapeutics Inc (NASDAQ:LSTA) has received a Paediatric Investigation Plan (PIP) waiver from the European Medicines Agency (EMA) for its…
Lisata Therapeutics reports strong 1Q performance, cash to support operations into 2026
Lisata Therapeutics Inc (NASDAQ:LSTA) has ended its first quarter of 2024 with nearly $43.3 million in cash to fund its…